文献速递小儿眼科与斜弱视

阈下弱视:一个新队列的特征描述

Subthreshold Amblyopia: Characterization of a New Cohort.
PubMed 文献 · Am J Ophthalmol · 2022-12-18

该回顾性临床队列研究纳入2010至2014年波士顿儿童医院诊断为弱视的全部患者,其中464例(20.1%)为阈下弱视(视力优于20/40但无法矫正至20/20)。随访318例中47.8%双眼视力恢复至20/20,获得恢复者立体视中位数改善0.4 log单位;多因素分析显示随访时间较长与恢复显著相关(OR 1.38,95%CI 1.22-1.57,P<.001)。

要点

  • 在2311例弱视患者中,464例(20.1%)为阈下弱视,多数(61.7%)存在弱视致病因素,最常见为屈光参差(32.8%)。
  • 318例随访患者中47.8%双眼视力恢复至20/20,其中初治患者恢复比例为55.7%,仅建议观察的8例中5例(62.5%)恢复。
  • 获得恢复者立体视中位数改善0.4 log单位,持续弱视者无变化;随访时间较长与恢复显著相关(OR 1.38,95%CI 1.22-1.57,P<.001)。

核心结论

  • 阈下弱视在真实世界弱视诊疗中构成相当规模的人群,接受治疗者约半数双眼视力恢复至20/20且立体视改善。
  • 尚需进一步研究评估仅观察是否可获得相似结局。

研究设计与样本

  • 回顾性临床队列研究,设置于机构临床实践。
  • 纳入2010至2014年波士顿儿童医院诊断为弱视的全部患者,共审查2311例。
  • 纳入标准为单眼或双眼视力优于20/40但无法矫正至20/20,年龄2至12岁。
  • 观察指标包括人口学特征、视力及基线特征;结局指标为恢复(双眼视力20/20)及末次随访时的立体视。

主要发现

  • 2311例中464例(20.1%)为阈下弱视。
  • 61.7%存在弱视致病因素,最常见为屈光参差(32.8%)。
  • 随访中位时间3.1年,97.5%接受治疗。
  • 318例返回随访者中47.8%获得恢复,包括初治患者的55.7%及仅建议观察的8例中的5例(62.5%)。
  • 获得恢复者立体视中位数改善0.4 log单位,持续弱视者无变化;多因素分析中随访时间较长与恢复显著相关(OR 1.38,95%CI 1.22-1.57,P<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出尚需进一步研究评估仅观察是否可获得相似结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Published studies of amblyopia include only patients with visual acuity (VA) worse than 20/40 in one or both eyes. The purpose of this study is to evaluate patients diagnosed and treated as amblyopic despite not meeting traditional VA criteria for amblyopia. DESIGN: Retrospective clinical cohort study. METHODS: Setting: Institutional practice. PATIENT POPULATION: All patients diagnosed with amblyopia at Boston Children's Hospital between 2010 and 2014. INCLUSION CRITERIA: VA better than 20/40 but not correctable to 20/20 in one or both eyes; age 2 to 12 years. OBSERVATIONS: Demographics, VA, baseline characteristics. OUTCOME MEASURES: Resolution, defined as VA 20/20 in both eyes; stereopsis at the last follow-up. RESULTS: Of 2311 patients reviewed, 464 (20.1%) had subthreshold amblyopia. A majority (61.7%) had an amblyogenic factor, most commonly anisometropia (32.8%). Patients were followed for a median of 3.1 years; nearly all (97.5%) were treated. Of 318 patients who returned for follow-up, 47.8% achieved resolution, including 55.7% of treatment-naïve patients, and 62.5% (5 of 8 patients) offered observation alone. Median stereopsis improved by 0.4 log units in those who achieved resolution, with no change in those with persistent amblyopia. In the multivariate analysis, a longer length of follow-up was significantly associated with resolution of subthreshold amblyopia (odds ratio: 1.38; 95% confidence interval: 1.22-1.57, P < .001). CONCLUSIONS: Patients with subthreshold amblyopia represent a sizeable cohort in real-world amblyopia practice. When offered treatment, half achieved 20/20 vision in both eyes with improved stereopsis as well. Further studies are needed to assess whether observation alone would result in similar outcomes.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Michalak SM, Chinn RN, Shoshany TN, et al. Subthreshold Amblyopia: Characterization of a New Cohort. Am J Ophthalmol. 2022. PMID: 36543314. doi:10.1016/j.ajo.2022.12.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。